Phoenix Reception and Book Signing with Sally Pipes

October 1, 2018
4455 East Camelback Road, Phoenix, AZ, USA
150320221647327682

Please Join PRI For An Evening Reception With

Sally C. Pipes

PRI’s President, CEO, and Thomas W. Smith Fellow
in Health Care Policy,
who will discuss her newly published book
The False Promise of Single-Payer Health Care

As the siren call for a single-payer health care system gains momentum at the national level
and in several states, Sally C. Pipes makes the case against such a system by offering
evidence of its devastating effects on patients in Canada, the United Kingdom, and
even the United States. Long wait times, substandard care, lack of access to innovative treatments,
huge public outlays, and spiraling costs are endemic to single-payer.

*Complimentary autographed books to be provided.

PRESENTATION AND BOOK SIGNING
Monday, October 1, 2018
6 p.m. to 8 p.m.

Cocktail Reception*

The Henry
4455 E. Camelback Road
Phoenix, AZ 85018

General Admission: Free

For more information, please contact Laura Dannerbeck, Events Consultant, at (415) 250-9206 or via email at [email protected].

 

window.bboxInit = function () {
bbox.showForm(‘cc8a6c1c-1ab8-4804-9656-a2d5b196fb63’);
};
(function () {
var e = document.createElement(‘script’); e.async = true;
e.src = ‘https://bbox.blackbaudhosting.com/webforms/bbox-min.js’;
document.getElementsByTagName(‘head’)[0].appendChild(e);
} ());

Tell Your Friends

Related

Health pina messina kfJkpeI6Lgc unsplash

Read part 3 of a series on drug pricing

Regulations, Not Anticompetitive Actions, Are Obstructing Drug Competition

The flaws driving up costs across the broader health care landscape are also driving up the costs for innovative drugs. After all, pharmaceuticals are an ...

America Doesn’t Have Enough Doctors. Medicare Is Making That Worse.

The United States is facing a shortage of 37,000 physicians, according to the latest research from the Association of American Medical Colleges. That deficit will ...
Prescription

How Price Controls Make a Healthy Drug Market Sick

The unspoken assumption behind the prescription drug price controls at the heart of the Democrats’ August 2022 Inflation Reduction Act (IRA) is that the pharmaceutical ...
Scroll to Top